In today’s market, where affordability is stretched thin and borrower competition is fierce, lenders can’t afford to stop at “yes.” The real differentiator isn’t just qualifying a borrower for a loan ...

In 2025, fewer biotech deals are getting done, but the dollars behind them are bigger than ever. Having spent years working with emerging and fast-growth life sciences companies, I’ve seen firsthand ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Kelly talks to Martin Dubin, a clinical ...